A detailed history of Exchange Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exchange Capital Management, Inc. holds 43,002 shares of BMY stock, worth $2.44 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
43,002
Previous 43,919 2.09%
Holding current value
$2.44 Million
Previous $1.82 Million 22.05%
% of portfolio
0.38%
Previous 0.31%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$39.66 - $51.75 $36,368 - $47,454
-917 Reduced 2.09%
43,002 $2.23 Million
Q2 2024

Jul 23, 2024

BUY
$40.25 - $52.99 $353,556 - $465,464
8,784 Added 25.0%
43,919 $1.82 Million
Q1 2024

Apr 18, 2024

BUY
$47.98 - $54.4 $2,399 - $2,720
50 Added 0.14%
35,135 $1.91 Million
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $61,084 - $72,891
-1,260 Reduced 3.47%
35,085 $1.8 Million
Q3 2023

Oct 30, 2023

SELL
$57.89 - $64.73 $80,698 - $90,233
-1,394 Reduced 3.69%
36,345 $2.11 Million
Q2 2023

Jul 24, 2023

SELL
$63.71 - $70.74 $32,938 - $36,572
-517 Reduced 1.35%
37,739 $2.41 Million
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $13,864 - $15,725
211 Added 0.55%
38,256 $2.65 Million
Q4 2022

Jan 31, 2023

SELL
$68.48 - $81.09 $135,932 - $160,963
-1,985 Reduced 4.96%
38,045 $2.74 Million
Q3 2022

Oct 31, 2022

SELL
$0.13 - $76.84 $3,309 - $1.96 Million
-25,461 Reduced 38.88%
40,030 $2.85 Million
Q2 2022

Jul 28, 2022

SELL
$72.62 - $79.98 $680,376 - $749,332
-9,369 Reduced 12.52%
65,491 $5.04 Million
Q1 2022

Apr 28, 2022

SELL
$61.48 - $73.72 $5,164 - $6,192
-84 Reduced 0.11%
74,860 $5.47 Million
Q4 2021

Jan 27, 2022

BUY
$53.63 - $62.52 $8,205 - $9,565
153 Added 0.2%
74,944 $4.67 Million
Q3 2021

Nov 01, 2021

SELL
$59.17 - $69.31 $133,724 - $156,640
-2,260 Reduced 2.93%
74,791 $4.43 Million
Q2 2021

Aug 05, 2021

BUY
$61.91 - $67.42 $6,314 - $6,876
102 Added 0.13%
77,051 $5.15 Million
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $334,499 - $376,213
5,637 Added 7.9%
76,949 $4.86 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $718,516 - $814,210
12,444 Added 21.14%
71,312 $4.42 Million
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $125,484 - $139,053
2,185 Added 3.85%
58,868 $3.55 Million
Q2 2020

Aug 04, 2020

SELL
$54.82 - $64.09 $46,487 - $54,348
-848 Reduced 1.47%
56,683 $3.33 Million
Q1 2020

Apr 28, 2020

SELL
$46.4 - $67.43 $47,560 - $69,115
-1,025 Reduced 1.75%
57,531 $3.21 Million
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $65,990 - $86,078
1,341 Added 2.34%
58,556 $3.76 Million
Q3 2019

Nov 07, 2019

BUY
$42.77 - $50.71 $2.45 Million - $2.9 Million
57,215 New
57,215 $2.9 Million
Q4 2018

Feb 01, 2019

SELL
$48.76 - $63.23 $17,163 - $22,256
-352 Closed
0 $0
Q3 2018

Oct 25, 2018

BUY
$55.19 - $62.25 $19,426 - $21,912
352 New
352 $22,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Exchange Capital Management, Inc. Portfolio

Follow Exchange Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Exchange Capital Management, Inc. with notifications on news.